Companies: 10,795·Total market cap: $144.5T
Bausch Health Companies Inc.

Bausch Health Companies Inc.

BHCNYSEHealthcare● Active
$5.16
$-0.21(-3.91%)
Market Cap$1.9B
P/E Ratio
52W High$8.69
52W Low$4.61

Bausch Health Companies Inc. (BHC) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · BHC · as of Sep 30, 2025

Ownership Breakdown

Institutions 64.41%
Insiders 11.56%
Public 24.04%

242

Institutional Holders

▲ 11 vs Q2

$1.55B

Total Inst. Value

▼ $86.27M vs Q2

373.48M

Shares Outstanding

freeFloat 88.44%

240.54M

13F Shares Held

▼ 5.65M vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

BHC largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

PAULSON & CO. INC.

pharmaceutical preparations

70.76M19.08%

19.08%

$456.38BNov 14, 2025 37.96M

GOLDENTREE ASSET MANAGEMENT LP

pharmaceutical preparations

34.83M9.39%

9.39%

$224.41BNov 14, 2025 578.5K

NOMURA HOLDINGS INC

pharmaceutical preparations

15.71M4.24%

4.24%

$101.32BNov 14, 2025 5.79M

HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND

pharmaceutical preparations

13.00M3.50%

3.50%

$83.85BNov 13, 2025— held

VANGUARD GROUP INC

pharmaceutical preparations

12.24M3.30%

3.30%

$78.81BNov 7, 2025 471.0K

ROYAL BANK OF CANADA

pharmaceutical preparations

10.51M2.83%

2.83%

$67.77BNov 14, 2025 1.16M

NATIONAL BANK OF CANADA /FI/

pharmaceutical preparations

7.72M2.08%

2.08%

$49.80BNov 14, 2025 16.6K

MFN PARTNERS MANAGEMENT, LP

pharmaceutical preparations

6.00M1.62%

1.62%

$38.70BNov 13, 2025— held

KOHLBERG KRAVIS ROBERTS & CO. L.P.

pharmaceutical preparations

5.24M1.41%

1.41%

$33.77BNov 14, 2025— held

UBS GROUP AG

pharmaceutical preparations

5.15M1.39%

1.39%

$33.21BNov 13, 2025 4.17M

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBullish — more buying than selling

20

Increased

+52.38M shares

2

New Positions

first time holders

18

Decreased

−22.80M shares

0

Sold Out

fully exited

Net shares change (top 50)

+29.57M

+52.38M / −22.80M

Net new holders

+4

2 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

BHC insider trading · insider activity

Source: SEC Form 4

Buy 0%Active transactions only100% Sell

Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.

0

Buy transactions

1

Sell transactions

0.00

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

WECHSLER AMY B

director

May 22, 2026Award45,871313.6KForm 4 ↗

ROBERTS EIRY

director

May 22, 2026Award45,87145.9KForm 4 ↗

POWER ROBERT N

director

May 22, 2026Award45,871300.6KForm 4 ↗

Paulson John

director

May 22, 2026Award45,871417.6KForm 4 ↗

LEUNG SANDRA

director

May 22, 2026Award45,87190.2KForm 4 ↗

Lee Frank D.

director

May 22, 2026Award45,87195.2KForm 4 ↗

KAVANAGH SARAH B

director

May 22, 2026Award45,871282.2KForm 4 ↗

GOETTLER MICHAEL

director

May 22, 2026Award45,87176.0KForm 4 ↗

Garcia Christian A

director

May 22, 2026Award45,871135.6KForm 4 ↗

Lee Frank D.

director

May 19, 2026Sale24,456$5.43$132.8K49.3KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Bausch Health Companies Inc. (BHC) is primarily owned by institutional investors, who hold approximately 64.4% of total shares outstanding. Company insiders own approximately 11.56%, while retail and public investors account for the remaining 24.04%.

The largest institutional shareholder of Bausch Health Companies Inc. is PAULSON & CO. INC., holding approximately 70.76 million shares — equal to 19.08% of outstanding shares — as of September 30, 2025.

A total of 242 institutional investors currently hold BHC stock, with a combined institutional value of approximately $1.55 billion as of the most recent 13F filing period.

Frequently asked questions

BHC ownership

Bausch Health Companies Inc. (BHC) is primarily owned by institutional investors, who hold approximately 64.4% of shares. The largest shareholder is PAULSON & CO. INC. with a 19.08% stake. Company insiders hold 11.56%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns BHC stockBHC ownership structureSEC Form 13F institutional holdingsBHC float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025